Status:
UNKNOWN
Impact of the Pre-phonatory Inspiratory Volume on the Speech Quality of Neuromuscular Patients Dependent on Non-invasive Ventilation
Lead Sponsor:
Centre d'Investigation Clinique et Technologique 805
Conditions:
Neuromuscular Diseases
Non Invasive Ventilation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We want to demonstrate that modifications of the ventilation parameters are liable to improve the different characteristics of phonation (duration, intensity, prosody..) in neuromuscular patients who ...
Detailed Description
Speech and communication quality depend on respiration efficiency. The respiratory involvement observed in neuromuscular disorders can impair speech quality in patients, while the underlying disease m...
Eligibility Criteria
Inclusion
- adult patients (age \> or equal to 18)
- chronic restrictive respiratory failure due to neuromuscular disease
- spontaneous breathing autonomy of at least one hour during the days
- stable clinical state
- patient with middle school education level (able to read)
- patients using life support ventilator ((Astral 150 (ResMed®), Elysée (ResMed®), Trilogy (Philips Respironics®), VentilogicLS (Weinman®), Vivo 40 (Breas®), PB560 ou Légendair (Covidien®), Monal T50 (Air liquide system®))
Exclusion
- refusal to participate
- unability to cooperate
- illiterate patients
- tracheostomised patients
- spontaneous breathing autonomy \< 1h
- cardiovascular instability
- not registered with the social security system
Key Trial Info
Start Date :
February 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03381937
Start Date
February 6 2018
End Date
January 1 2020
Last Update
August 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Raymond Poincaré hospital
Garches, France, 92380